PDCD1 and cancer: Most advanced MSI cancers express high levels of immune checkpoint proteins, including PD-1, PD-L1, CTLA-4, LAG-3, and IDO, that help these cells evade immune destruction by TILs, and create an immunosuppressive tumor microenvironment (TME) (3, 4).